Why Gene-Editing Pioneer Editas Skyrocketed 28.8% in August – Madison.com
Madison.comWhy Gene-Editing Pioneer Editas Skyrocketed 28.8% in AugustMadison.comEditas Medicine also said it bolstered its patent portfolio by adding a patent for CRISPR-Cpf1, a second gene-editing approach that could increase the number of genomic si… Continue reading
